This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Frank J. Lowery, III: Innovator in T Cell Receptor Development
Introduction
Frank J. Lowery, III is a notable inventor based in Clarksburg, MD (US). He has made significant contributions to the field of immunology, particularly in the development of T cell receptors. With a total of 4 patents, his work has the potential to impact therapeutic approaches in cancer treatment.
Latest Patents
Lowery's latest patents include "HLA Class II-Restricted DQ T Cell Receptors Against RAS with G13D Mutation" and "HLA Class II-Restricted DRB T Cell Receptors Against RAS with G12V Mutation." These innovations focus on enhancing the immune response against specific mutations in the RAS gene, which is often implicated in various cancers.
Career Highlights
He is currently employed by the United States of America, as represented by the Secretary, Department of Health and Human Services. His role involves advancing research that could lead to new therapeutic strategies for cancer patients.
Collaborations
Lowery has collaborated with esteemed colleagues such as Noam Levin and Steven A. Rosenberg. Their combined expertise contributes to the innovative research being conducted in the field of T cell receptor development.
Conclusion
Frank J. Lowery, III is a dedicated inventor whose work in T cell receptor development is paving the way for future advancements in cancer therapy. His contributions are vital to the ongoing research in immunology and cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile